NanoLogix said today it inked a deal with “1 of the world’s 3 largest medical device manufacturers” to customize its NanoLogix N-Assay, a modified ELISA diagnostic device. NanoLogix is a rapid diagnostic and petri plate focused biotech company. Its N-Assay is designed to detect and identify bacteria for which an antibody exists, and can also […]
Medtronic Inc. (NYSE:MDT) said the results of a clinical trial for its new remote monitoring network indicate that the system reduces healthcare costs.
The study showed that monitoring of implantable cardiac device patients with the Medtronic’s CareLink network and CareAlert notification system cuts down on healthcare utilization costs when compared to in-office follow-up appointments, according to the company.